---
layout: default
title: Clomipramine
description: "Clomipramine çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 50
evidence_level: L5
indication_count: 10
---

# Clomipramine

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Clomipramine è—¥å¸«ç­†è¨˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Clomipramine å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Clomipramine æ˜¯ç¶“å…¸çš„ä¸‰ç’°æŠ—æ†‚é¬±åŠ‘ï¼ŒTxGNN é æ¸¬å…¶å°ç„¦æ…®ç—‡æœ‰ç™‚æ•ˆï¼Œé€™èˆ‡å…¶å·²çŸ¥çš„è—¥ç†ä½œç”¨åŠè±å¯Œçš„è‡¨åºŠè­‰æ“šé«˜åº¦å»åˆï¼Œå±¬æ–¼è­‰æ“šå……è¶³çš„ã€Œè€è—¥æ—¢æœ‰ç”¨é€”ã€ã€‚
</p>


---

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Clomipramine (å¯æ´›ç±³æ™®æ˜) |
| DrugBank ID | DB01242 |
| å°ç£å•†å“å | å€æ¬£è†œè¡£éŒ  25 å…¬çµ² ç­‰å¤šç¨®è£½åŠ‘ |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | æ†‚é¬±ç—‡ã€å¼·è¿«ç—‡ã€ææ‡¼ç—‡ã€é©šæ‡¼ç™¼ä½œ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | ç„¦æ…®ç—‡ã€obsessive-compulsive disorderã€benign paroxysmal torticollis of infancyã€schizotypal personality disorderã€histrionic personality disorder (disease)ã€paranoid personality disorderã€schizoid personality disorderã€agoraphobiaã€major depressive disorderã€endogenous depression |
| æœ€é«˜é æ¸¬åˆ†æ•¸ | 0.999 (anxiety disorder) |
| è­‰æ“šç­‰ç´š | L1-L2 (å¤šå€‹ RCT/ç³»çµ±æ€§å›é¡§) |

---

## ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†

Clomipramine çš„è—¥ç†æ©Ÿè½‰å®Œå…¨æ”¯æŒå…¶å°ç„¦æ…®ç—‡çš„ç™‚æ•ˆï¼š

1. **è¡€æ¸…ç´ å†å¸æ”¶æŠ‘åˆ¶**ï¼šClomipramine æ˜¯ä¸‰ç’°æŠ—æ†‚é¬±åŠ‘ä¸­è¡€æ¸…ç´ é¸æ“‡æ€§æœ€é«˜è€…ï¼Œå…¶æ´»æ€§ä»£è¬ç‰© desmethylclomipramine å‰‡æŠ‘åˆ¶æ­£è…ä¸Šè…ºç´ å†å¸æ”¶
2. **æŠ—ç„¦æ…®æ©Ÿè½‰æ˜ç¢º**ï¼šè¡€æ¸…ç´ ç³»çµ±å¤±èª¿æ˜¯ç„¦æ…®ç—‡çš„æ ¸å¿ƒç—…ç†æ©Ÿè½‰ï¼Œå¢åŠ è¡€æ¸…ç´ å‚³å°å¯æ”¹å–„ç„¦æ…®ç—‡ç‹€
3. **è‡¨åºŠç¶“é©—è±å¯Œ**ï¼šClomipramine å·²å»£æ³›ç”¨æ–¼å¼·è¿«ç—‡ (OCD)ã€ææ…Œç—‡ç­‰ç„¦æ…®ç›¸é—œç–¾æ‚£ï¼Œç™‚æ•ˆç¢ºç«‹

å¯¦éš›ä¸Šï¼Œã€Œç„¦æ…®ç—‡ã€çš„é æ¸¬åæ˜ çš„æ˜¯ clomipramine å·²çŸ¥çš„æ²»ç™‚è­œç³»ï¼Œè€ŒéçœŸæ­£çš„æ–°é©æ‡‰ç—‡ç™¼ç¾ã€‚

---

## è‡¨åºŠè©¦é©—è­‰æ“š

### ä»£è¡¨æ€§è‡¨åºŠè©¦é©—

| è©¦é©—ç·¨è™Ÿ | æ¨™é¡Œ | éšæ®µ | ç‹€æ…‹ | ä¸»è¦ç™¼ç¾ |
|----------|------|------|------|----------|
| NCT03299166 | Troriluzole è¼”åŠ©æ²»ç™‚ OCD | Phase 2/3 | å·²å®Œæˆ | è©•ä¼°å° SSRI/clomipramine åæ‡‰ä¸ä½³æ‚£è€…çš„è¼”åŠ©æ²»ç™‚ |
| NCT00004310 | IV vs Oral Clomipramine in OCD | Phase 2 | ç‹€æ…‹ä¸æ˜ | æ¯”è¼ƒéœè„ˆæ³¨å°„èˆ‡å£æœ clomipramine ç™‚æ•ˆ |
| NCT00466609 | OCD åŠ å¼·æ²»ç™‚ç­–ç•¥ | Phase 4 | å·²å®Œæˆ | æ¯”è¼ƒ fluoxetine + clomipramine vs fluoxetine + quetiapine |
| NCT00074815 | å…’ç«¥ OCD çš„ SRI éƒ¨åˆ†åæ‡‰è€…æ²»ç™‚ | Phase 3 | å·²å®Œæˆ | èªçŸ¥è¡Œç‚ºæ²»ç™‚å¯æ”¹å–„ SRI æ²»ç™‚æ•ˆæœ |

**é—œéµç™¼ç¾**ï¼šå¤šé …è‡¨åºŠè©¦é©—è­‰å¯¦ clomipramine å°å¼·è¿«ç—‡åŠç›¸é—œç„¦æ…®ç–¾æ‚£æœ‰æ•ˆï¼Œæ˜¯ OCD æ²»ç™‚çš„ä¸€ç·šè—¥ç‰©é¸æ“‡ã€‚

---

## æ–‡ç»è­‰æ“š

### ç³»çµ±æ€§å›é¡§èˆ‡ Meta åˆ†æ

| PMID | æ¨™é¡Œ | å¹´ä»½ | ä¸»è¦çµè«– |
|------|------|------|----------|
| 38014714 | Pharmacological treatments in panic disorder - network meta-analysis | 2023 | Clomipramine æ˜¯ææ…Œç—‡æœ‰æ•ˆæ²»ç™‚é¸é … |
| 34582562 | Pharmacotherapy for trichotillomania | 2021 | Clomipramine å°æ‹”æ¯›ç—‡æœ‰æ•ˆ |
| 27663940 | SSRI and Clomipramine in Pediatric OCD - meta-analysis | 2016 | ç¢ºèª clomipramine å°å…’ç«¥ OCD æœ‰æ•ˆ |
| 25681005 | OCD: Practical strategies for pharmacological treatment | 2015 | Clomipramine èˆ‡ SSRI ç‚º OCD ä¸€ç·šæ²»ç™‚ |

### è‡¨åºŠæŒ‡å¼•æ”¯æŒ

- **åœ‹éš› OCD æ²»ç™‚æŒ‡å¼•**ï¼šå°‡ clomipramine åˆ—ç‚ºèˆ‡ SSRI ä¸¦åˆ—çš„ä¸€ç·šè—¥ç‰©æ²»ç™‚
- **ææ…Œç—‡æ²»ç™‚æŒ‡å¼•**ï¼šèªå¯ clomipramine ç‚ºæœ‰æ•ˆçš„è—¥ç‰©é¸æ“‡

---

## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰å­—è™Ÿ | å•†å“å | é©æ‡‰ç—‡ | åŠ‘å‹ | ç‹€æ…‹ |
|------------|--------|--------|------|------|
| å¤šé …è¨±å¯è­‰ | å€æ¬£è†œè¡£éŒ ç­‰ | æ†‚é¬±ç—…ã€å¼·è¿«ç—‡ã€ææ‡¼ç—‡ã€é©šæ‡¼ç™¼ä½œ | éŒ åŠ‘/è† å›Š | æœ‰æ•ˆ |

**å‚™è¨»**ï¼šå°ç£æ ¸å‡†é©æ‡‰ç—‡å·²åŒ…å«ã€Œææ‡¼ç—‡ã€åŠã€Œé©šæ‡¼ç™¼ä½œã€ï¼Œå¯¦è³ªä¸Šæ¶µè“‹äº†ç„¦æ…®ç—‡çš„ä¸»è¦é¡å‹ã€‚

---

## å®‰å…¨æ€§è€ƒé‡

### é‡è¦è­¦èª

1. **å¿ƒè‡Ÿæ¯’æ€§**ï¼šå¯èƒ½å»¶é•· QT é–“æœŸï¼Œå¿ƒè‡Ÿç—…æ‚£è€…éœ€è¬¹æ…ä½¿ç”¨
2. **æŠ—è†½é¹¼å‰¯ä½œç”¨**ï¼šå£ä¹¾ã€ä¾¿ç§˜ã€å°¿æ»¯ç•™ã€è¦–åŠ›æ¨¡ç³Š
3. **é®éœä½œç”¨**ï¼šå¯èƒ½å½±éŸ¿é§•é§›åŠæ“ä½œæ©Ÿæ¢°èƒ½åŠ›
4. **éé‡ä¸­æ¯’é¢¨éšª**ï¼šä¸‰ç’°æŠ—æ†‚é¬±åŠ‘éé‡å¯èƒ½è‡´å‘½
5. **å¹´è¼•äººè‡ªæ®ºé¢¨éšª**ï¼š18-24 æ­²æ‚£è€…åˆæœŸæ²»ç™‚éœ€å¯†åˆ‡ç›£æ¸¬

### è—¥ç‰©äº¤äº’ä½œç”¨æ³¨æ„äº‹é …

- **MAO æŠ‘åˆ¶åŠ‘**ï¼šç¦æ­¢ä½µç”¨ï¼Œå¯èƒ½å°è‡´è¡€æ¸…ç´ ç—‡å€™ç¾¤
- **CYP2D6 æŠ‘åˆ¶åŠ‘**ï¼šå¯èƒ½å¢åŠ  clomipramine è¡€ä¸­æ¿ƒåº¦
- **ä¸­æ¨ç¥ç¶“æŠ‘åˆ¶åŠ‘**ï¼šåŠ å¼·é®éœä½œç”¨
- **æŠ—è†½é¹¼è—¥ç‰©**ï¼šåŠ é‡æŠ—è†½é¹¼å‰¯ä½œç”¨

### CYP450 ä»£è¬è€ƒé‡

Clomipramine ç¶“ç”± CYP2C19 åŠ CYP2D6 ä»£è¬ã€‚æ–‡ç»å ±å‘Š (PMID: 28470111) é¡¯ç¤ºï¼ŒCYP2C19 åŠ CYP2D6 ä¸­é–“ä»£è¬è€…å¯èƒ½å‡ºç¾é¡¯è‘—å‡é«˜çš„è—¥ç‰©è¡€ä¸­æ¿ƒåº¦ï¼Œå»ºè­°è€ƒæ…®è—¥ç‰©åŸºå› æª¢æ¸¬ã€‚

---

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**é…’ç²¾ (alcohol)** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šThe combination of ethanol and a tricyclic antidepressant may result in additive impairment of motor skills, especially driving skills.  Also, one study has suggested that clomipramine metabolism is s...
- å»ºè­°ï¼šPatients should be warned of this interaction and advised to limit their ethanol intake while taking tricyclic antidepressants.  Monitoring for TCA toxicity (CNS depression, excessive anticholinergic ...

**è‘¡è„æŸšæ± (grapefruit juice)** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šLimited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially ...
- å»ºè­°ï¼šPatients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.

**cranberry juice** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šLimited data suggest that the administration of clomipramine with grapefruit juice or cranberry juice may significantly increase plasma drug concentrations of clomipramine.  Clomipramine is initially ...
- å»ºè­°ï¼šPatients receiving clomipramine therapy who ingest cranberry juice, grapefruits, or grapefruit juice should be monitored for adverse effects and undue fluctuations in plasma drug levels.

### è—¥ç‰©-è‰è—¥äº¤äº’ä½œç”¨ (DHI)

**è–ç´„ç¿°è‰ï¼ˆè²«è‘‰é€£ç¿¹ï¼‰** ğŸ”´ Major
- å½±éŸ¿ï¼šä½µç”¨å¯èƒ½å°è‡´è¡€æ¸…ç´ ç—‡å€™ç¾¤
- å»ºè­°ï¼šç¦æ­¢ä½µç”¨

**å¡ç“¦** ğŸ”´ Major
- å½±éŸ¿ï¼šå¡ç“¦å¢å¼·ä¸­æ¨ç¥ç¶“æŠ‘åˆ¶ä½œç”¨
- å»ºè­°ï¼šé¿å…ä½µç”¨

**çºˆè‰** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šçºˆè‰å¯èƒ½å¢å¼·é®éœä½œç”¨
- å»ºè­°ï¼šè¬¹æ…ä½¿ç”¨


## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### é æ¸¬è©•ä¼°

| è©•ä¼°é …ç›® | çµæœ |
|----------|------|
| æ©Ÿè½‰åˆç†æ€§ | é«˜ - è¡€æ¸…ç´ /æ­£è…ä¸Šè…ºç´ å†å¸æ”¶æŠ‘åˆ¶å°ç„¦æ…®ç—‡æœ‰æ˜ç¢ºç™‚æ•ˆ |
| è‡¨åºŠè­‰æ“š | å……è¶³ - å¤šé … RCT åŠ meta-analysis æ”¯æŒ |
| æ–‡ç»æ”¯æŒ | å¼· - åœ‹éš›æŒ‡å¼•æ¨è–¦ |
| æ•´é«”è­‰æ“šç­‰ç´š | **L1-L2 (å¤šå€‹ RCT/ç³»çµ±æ€§å›é¡§)** |

### è‡¨åºŠå»ºè­°

1. **å·²å¯è‡¨åºŠä½¿ç”¨**ï¼šClomipramine å°ç„¦æ…®ç›¸é—œç–¾æ‚£ï¼ˆç‰¹åˆ¥æ˜¯ OCDã€ææ…Œç—‡ï¼‰çš„ç™‚æ•ˆå·²ç²ç¢ºèª
2. **é©æ‡‰ç—‡è€ƒé‡**ï¼šå°ç£æ ¸å‡†é©æ‡‰ç—‡å·²æ¶µè“‹å¤šç¨®ç„¦æ…®ç–¾æ‚£ï¼Œç¬¦åˆä»¿å–®é©æ‡‰ç—‡ä½¿ç”¨
3. **è™•æ–¹æ³¨æ„äº‹é …**ï¼š
   - èµ·å§‹åŠ‘é‡å®œä½ï¼Œç·©æ…¢èª¿å‡
   - ç›£æ¸¬å¿ƒé›»åœ–ï¼Œç‰¹åˆ¥æ˜¯æœ‰å¿ƒè‡Ÿç—…å²è€…
   - æ³¨æ„å¹´è¼•æ‚£è€…çš„è‡ªæ®ºé¢¨éšª
   - é¿å…çªç„¶åœè—¥

### çµèª

æ­¤é æ¸¬é©—è­‰äº† TxGNN çŸ¥è­˜åœ–è­œæ–¹æ³•èƒ½æº–ç¢ºè­˜åˆ¥è—¥ç‰©çš„å·²çŸ¥æ²»ç™‚æ½›åŠ›ã€‚Clomipramine å°ç„¦æ…®ç—‡çš„ç™‚æ•ˆå·²æœ‰å …å¯¦çš„è­‰æ“šåŸºç¤ï¼Œå±¬æ–¼ã€Œå†ç™¼ç¾ã€è€Œéã€Œæ–°ç™¼ç¾ã€ã€‚

---

*æœ¬ç­†è¨˜åƒ…ä¾›ç ”ç©¶åƒè€ƒï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€‚ä»»ä½•ç”¨è—¥æ±ºç­–æ‡‰è«®è©¢å°ˆæ¥­é†«ç™‚äººå“¡ã€‚*

*æœ€å¾Œæ›´æ–°ï¼š2026-02-11*


---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Amorolfine]({{ "/drugs/amorolfine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Urea]({{ "/drugs/urea/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Paclitaxel]({{ "/drugs/paclitaxel/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Cobicistat]({{ "/drugs/cobicistat/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Xylometazoline]({{ "/drugs/xylometazoline/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Clomipramineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/clomipramine/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_clomipramine,
  title = {Clomipramineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/clomipramine/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
